Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease
NCT00862420
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
431
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Arterial Disease (PAD)
Interventions
DRUG:
clopidogrel (SR25990)
DRUG:
ticlopidine
Sponsor
Sanofi